| Financial Year |
March 31 2023 |
| Monetary Funds |
925,411,044.97 |
| Held-for-trading Financial Assets |
250,000,000.00 |
| Notes Receivable |
1,784,930.50 |
| Accounts Receivable |
394,893,980.03 |
| Advances to Suppliers |
7,864,941.52 |
| Other Receivables |
6,383,045.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
143,316,789.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,394,525.43 |
| Total Current Assets |
1,766,207,977.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,302,685.65 |
| Investment Properties |
306,114,875.73 |
| Fixed Assetes |
270,712,392.26 |
| Under-construction Projects |
2,156,637.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
203,037,943.44 |
| R&D expenses |
-- |
| Goodwill |
216,923,762.03 |
| Long-Term Deferred and Prepaid Expenses |
20,019,047.02 |
| Deferred Income Tax Assets |
6,731,341.34 |
| Other Non-Current Assets |
36,581,531.94 |
| Sub-Total of Non-Current Assets |
1,276,309,889.89 |
| Total Assets |
3,042,517,867.03 |
| Short-Term Loans |
29,026,790.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
56,790,405.80 |
| Accounts Payable |
143,878,321.96 |
| Accounts Received In Advance |
3,511,371.71 |
| Employee Compensation Payable |
8,900,167.07 |
| Taxes Payable |
17,134,322.65 |
| Interest Payable |
-- |
| Dividend Payable |
2,300,000.00 |
| Other payables |
91,336,145.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,153,330.76 |
| Other Current Liabilities |
2,122,485.39 |
| Sub-Total of Current Liabilities |
397,138,515.94 |
| Long-term Loans |
17,350,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,834,222.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,845,722.44 |
| Total Liabilities |
436,984,238.38 |
| Paid-In Capital(Or Share Stock) |
935,575,000.00 |
| Capital Surplus |
1,352,471,617.02 |
| Surplus Reserve |
134,572,272.88 |
| LESS:Treasury Stock |
271,465,227.18 |
| Undistributed Profits |
265,793,714.70 |
| Minority Stockholder's Interest |
151,241,394.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,454,292,233.99 |
| Owner's Equity（Stockholder's Equity） |
2,605,533,628.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,042,517,867.03 |
